Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors
The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Abdominal pain is common in the general population and, in patients with irritable bowel syndrome, is attributed to visceral hypersensitivity. We found that oral administration of specific Lactobacillus strains induced the expression of mu-opioid and cannabinoid receptors in intestinal epithelial cells, and mediated analgesic functions in the gut-similar to the effects of morphine. These results suggest that the microbiology of the intestinal tract influences our visceral perception, and suggest new approaches for the treatment of abdominal pain and irritable bowel syndrome.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A few putative mechanisms include: microbial induction of epithelial μ-opioid and cannabinoid receptors as shown with oral administration of Lactobacillus strains in rodents69”
From The gut Microbiome in adult and pediatric functional gastrointestinal disorders (2019) · cites this paper as [69]
In the citing paper
“The use of probiotics, particularly in animal models, also demonstrates that their secreted products or metabolites can modulate contractility of intestinal smooth muscle and visceral sensitivity.59–61”
From Intestinal microbiota in functional bowel disorders: a Rome foundation report (2013) · cites this paper as [60]
In the citing paper
“Interestingly, we saw beneficial effects especially on distension and pain, as this agrees well with the recent findings that certain lactobacilli can induce the expression of pain-sensing receptors in intestinal epithelial cells. 33”
From Clinical trial: multispecies probiotic supplementation alleviates the symptoms of irritable bowel syndrome and stabilizes intestinal microbiota (2008) · cites this paper as [33]
In the citing paper
“In addition, exposure of rats to L. reuteri (83) or L. acidophilus NCFM (151) reduce their pain response to balloon distension, through targeting ion channels in the enteric nervous system (83, 91) or increasing the expression of μ-opioid and cannabinoid receptors in intestinal epithelial cells (151).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [151]
In the citing paper
“Evidence for such mutual interaction has been demonstrated in gut inflammation,14 visceral pain,77 certain symptoms of IBS,12 and in obesity.78”
From Principles and clinical implications of the brain-gut-enteric microbiota axis (2009) · cites this paper as [77]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Gut flora in health and disease
Guarner, F., & Malagelada, J.-R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12489-0 · Cited by 3,365
O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448
Falk, P. G., Hooper, L. V., Midtvedt, T., & Gordon, J. I. (1998) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.62.4.1157-1170.1998 · Cited by 657
Attacking pain at its source: new perspectives on opioids
Stein, C., Schäfer, M., & Machelska, H. (2003) · Nature Medicine · doi:10.1038/nm908 · Cited by 608
Complete genome sequence of the probiotic lactic acid bacterium Lactobacillus acidophilus NCFM
Altermann, E., Russell, W. M., Azcarate-Peril, M. A., Barrangou, R., Buck, B. L., McAuliffe, O., Souther, N., Dobson, A., Duong, T., Callanan, M., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409188102 · Cited by 590
Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice
Verdú, E. F., Bercik, P., Verma-Gandhu, M., Huang, X.-X., Blennerhassett, P., Jackson, W., Mao, Y., Wang, L., Rochat, F., & Collins, S. M. (2006) · Gut · doi:10.1136/gut.2005.066100 · Cited by 448
Cervero, F., & Laird, J. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)01306-9 · Cited by 434
Invited Review: The Scientific Basis of Lactobacillus acidophilus NCFM Functionality as a Probiotic
Sanders, M. E., & Klaenhammer, T. R. (2001) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(01)74481-5 · Cited by 433
KAJANDER, K., HATAKKA, K., POUSSA, T., FÄRKKILÄ, M., & KORPELA, R. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02579.x · Cited by 361
WRIGHT, K., ROONEY, N., FEENEY, M., TATE, J., ROBERTSON, D., WELHAM, M., & WARD, S. (2005) · Gastroenterology · doi:10.1016/j.gastro.2005.05.026 · Cited by 299
Cited by
Items 701–793 of 793
Pain in irritable bowel syndrome
Zielińska, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-821324-7.00010-1 · Cited by 2
Treatment with probiotics in functional dyspepsia
Blaga, T. S., Chira, A., & Dumitrascu, D. L. (2021) · NeuroGastroLATAM Reviews · doi:10.24875/ngl.20000010 · Cited by 3
The Physiology and Pharmacology of Diabetic Gastropathy Management
Dolan, R. D., Rohani, T. S., Muttineni, D., & Mashimo, H. L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00045-1 · Cited by 1
Role of Gut Microbiota and Probiotic in Chronic Fatigue Syndrome
Sharma, A., Wakode, S. R., Sharma, S., & Fayaz, F. (2022) · Springer eBooks · doi:10.1007/978-981-16-6760-2_9 · Cited by 2
Schoeni, J. L. (2015) · American Public Health Association eBooks · doi:10.2105/mbef.0222.025 · Cited by 1
Irritable bowel syndrome dietary management
Staudacher, H. M., & Parkes, G. C. (2014) · Wiley eBooks · doi:10.1002/9781118872796.ch3.19 · Cited by 1
Effects of Proatherogenic and Probiotic Bacteria on Mast Cells and Inflammation
Oksaharju, A. (2012) · Työväentutkimus Vuosikirja · Cited by 1
Ford, A. C., Moayyedi, P., & Talley, N. J. (2010) · Wiley eBooks · doi:10.1002/9781444314403.ch21 · Cited by 2
Studies of barrier function in patients with ulcerative colitis and pouchitis
Persborn, M. (2011) · DiVA (Digitala Vetenskapliga Arkivet)
Probiotica - von der intestinalen Relevanz zu neuen Anwendungsgebieten
Kneifel, W., & Domig, K. J. (2007) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Developing effective probiotic products: bioavailability and other factors
Lahtinen, S. J., Rautonen, N., Ouwehand, A. C., Henrikson, A., & Steele, P. M. (2009) · Elsevier eBooks · doi:10.1533/9781845696603.1.230
Self-citationMatricon, J. (2010) · OpenGrey (Institut de l'Information Scientifique et Technique)
Ernährung beim Reizdarmsyndrom
Meier, R. F. (2011) · Journal für Kardiologie (Krause & Pachernegg GmbH) · Cited by 3
Proceedings from the FFF Probiotics 2012 meeting in Turku, Finland, 11–13 June 2012
(2012) · Microbial Ecology in Health and Disease · doi:10.3402/mehd.v23i0.18868
Ventura, T., & Evangelina, D. (2009) · TDX (Tesis Doctorals en Xarxa) · Cited by 1
Microbiote et syndrome de l’intestin irritable (SII) : où en sommes-nous, où allons-nous ?
Duboc, H. (2013) · Côlon & Rectum · doi:10.1007/s11725-013-0459-5
THE ENDOCANNABINOID SYSTEM AND THE CONTROL OF GASTROINTESTINAL FUNCTION
Sharkey, K. A. (2008)
[Irritable bowel syndrome: a functional disorder?].
Man, F., & Fernández, L. M. B. (2013) · PubMed
Exploring the Link Between Gut Microbes and Obesity
Shanahan, F. (2007) · Future Microbiology · doi:10.2217/17460913.2.3.261
“In addition, contributions from the microbiota to intestinal physiology include the generation of immunoregulatory molecules and factors that influence enteric nervous perception [3–5].”
BackgroundLas posibilidades del empleo de lactobacilos en la gastroenterología y la nutrición humana
Oscar Brunser, T. (2013) · Revista chilena de nutrición · doi:10.4067/s0717-75182013000300012 · Cited by 2
“Savino y colaboradores (10) compararon sus propiedades en un estudio en doble ciego, randomizado y controlado con placebo practicado en lactantes con cólico amamantados en forma exclusiva: un grupo de 25 lactantes recibió L.”
BackgroundFunctional Abdominal Pain GG in Children With Lactobacillus A Randomized Controlled Trial of
Peccarisi, L., Indrio, F., Cavallo, L., Gagliardi, F., Lionetti, E., Castellaneta, S. P., Polimeno, L., Francavilla, R., Miniello, V. L., & Magistà, A. M. (2010)
Inflammation, Microflora, Motility, and Visceral Sensitivity
Michail, S. K., & Ng, M.-W. (2012) · Humana Press eBooks · doi:10.1007/978-1-60761-709-9_5
Duboc, H., Jouët, P., & Coffin, B. (2010)
Potentials of Probiotics as Alternative Therapy in Combating Bacterial Diseases: A Review
Salisu, S. (2014) · British Journal of Applied Science & Technology · doi:10.9734/bjast/2014/6577 · Cited by 1
“paracasei NCC2461 have been found to be effective in alleviating the symptoms of IBS in humans, rats, and mice [87-91].”
BackgroundCB2 receptor activation as a therapeutic target in inflammatory bowel diseases
Yahalom, B., Yacovan, A., Aizikovich, A., Mirilashvili, S., Galili, Z., Avidor, B., Konforti, D., Kischitzky, A., & Zawoznik, E. (2008) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200801001-00138
The Future of Prebiotics and Probiotics
Brunser, O., Bravo, J., & Gotteland, M. (2013) · CRC Press eBooks · doi:10.1201/b15561-24
Gut Microbiome in the Critically Ill
Cresci, G. (2015) · CRC Press eBooks · doi:10.1201/b18386-13
The gut microbiota and the CNS
Bharwani, A., & Forsythe, P. (2016) · Wiley eBooks · doi:10.1002/9781118982907.ch27
Droney, J. (2012) · Spiral (Imperial College London) · doi:10.25560/9252 · Cited by 1
Thijssen, A. Y. (2015) · Research Publications (Maastricht University) · doi:10.26481/dis.20151119at
Orel, R. (2013) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2
Medical Therapy of Hemorrhoidal Disease
Scaldaferri, F., Ingravalle, F., Zinicola, T., Holleran, G. E., & Gasbarrini, A. (2017) · Coloproctology · doi:10.1007/978-3-319-51989-0_6-1
“Of particular relevance to constipation, probiotics may also produce other chemicals, including neurotransmitters, which may modify other gut functions, such as motility (Quigley 2007; Bueno et al. 2007) or sensation (Rousseaux et al. 2007; Ait-Belgnaoui et al. 2006).”
BackgroundProspects for using probiotics in the treatment of constipation in children
Zakharova, I. N., Osmanov, I. M., Berezhnaya, I. V., Анатольевич, К. К., Dedikova, O. V., Kuchina, A. E., & Sazanova, Y. О. (2018) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2018-11-85-90
Fibromyalgia and the endocannabinoid system
McPartland, J. M. (2009) · Elsevier eBooks · doi:10.1016/b978-0-443-06936-9.00011-1 · Cited by 1
“Oral administration of Lactobacillus upregulated CB 2 in intestinal epithelial cells and relieved symptoms of irritable bowel syndrome (Rousseaux et al 2007).”
Irritable bowel syndrome and probiotics place in therapeutic strategies
Aramă, Ș.-S. (2018) · Infectio ro · doi:10.26416/inf.56.4.2018.2188
The endocannabinoid system: from the receptors to therapy
László-István, B., Melinda, K., Hack, B., Gáll, Z., & Zoltán, K. (2019) · Bulletin of Medical Sciences · doi:10.2478/orvtudert-2019-0002
“ját indukálja és csökkenti a hasi fájdalmat [60].”
An Insight into the Changing Scenario of Gut Microbiome during Type 2 Diabetes
Mukhuty, A., Fouzder, C., Das, S., & Chattopadhyay, D. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.90697
“Also probiotics control GM through CB2 receptor expression [77].”
BackgroundNociceptor Regulation of the Intestinal Immune Landscape During Salmonella Typhimurium Infection
Potts, D. E. (2019) · Digital Access to Scholarship at Harvard (DASH) (Harvard University)
Maixent, J. M., Pons, O., Sennoune, S. R., & Sadrin, S. (2020) · Archives of Clinical Gastroenterology · doi:10.17352/2455-2283.000075
Neurophysiology of Visceral Pain
Costa, P. (2020) · Urodynamics, neurourology and pelvic floor dysfunctions · doi:10.1007/978-3-030-56387-5_2
Nutritional Therapies for Irritable Bowel Syndrome: a Focus on Prebiotics and Probiotics
Zoll, B. E., & Ahuja, N. K. (2020) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-020-00320-z · Cited by 1
The relevance of probiotics in therapy
Grzeszczak, K., Strońska-Pluta, A., & Rogulska, K. (2021) · Journal of Education Health and Sport · doi:10.12775/jehs.2021.11.08.009
Young, W. (2011) · Otago University Research Archive (University of Otago)
Riché, D. (2017) · De Boeck Supérieur eBooks · doi:10.3917/dbu.riche.2017.02.0121
Hawrelak, J. A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-43044-9.00105-9 · Cited by 1
(2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283454167
(2018) · Journal of Translational Medicine · doi:10.1186/s12967-018-1671-8
Tarasiuk, A., Sałaga, M., & Fichna, J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65635-0
(2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1612
Evaluation of the effect of probiotics on celiac patients
Çalışır, B., Adiloğlu, A. K., & Berkem, R. (2022) · Kastamonu Medical Journal · doi:10.51271/kmj-0083
“(20), Lactobacillus acidophilus strain was shown to induce the expression of mu-opioid and cannabinoid receptors in intestinal epithelial cells and have analgesic functions similar to the effects of morphine in the intestine, thus shown to be effective in treating abdominal pain.”
Ali, M. (2020) · Annals of the Academy of Romanian Scientists Series on Biological Sciences · doi:10.56082/annalsarscibio.2020.2.50
The gut microbiota: A driver of Type 2 diabetes
Scheithauer, T. P. M. (2023) · doi:10.5463/thesis.82
Medicinal-microbial interactions and ways of correcting iatrogenic intestinal dysbiosis
Бакулин, И. Г., & Serkova, M. Y. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-207-11-26-35 · Cited by 1
Fixing the Damage: The Evolution of Probiotics from Fermented Food to Biotherapeutic Products
de Freitas, P. N. N., Silva, C. R., Constantin, P. P., Pileggi, S. A. V., Vicari, M. R., & Pileggi, M. (2023) · Springer eBooks · doi:10.1007/978-3-031-24942-6_12
Zhang, W., Lin, B., Lei, Y., Zhang, Y., Cao, Q., Xu, M., & Zhang, Y. (2023) · Research Square · doi:10.21203/rs.3.rs-2982257/v1
Pescatori, M. (2024) · Techniques in Coloproctology · doi:10.1007/s10151-023-02901-3
“Intestinal dysbiosis (rectum-colon-ileum), possibly favored by stress (P of PNEI), can be the key factor determining a low threshold for visceral pain (inverse feedback from the proctological “compartment” of the tricompart-mental procto-uro-gynecological system and the P of PNEI) [24].”
Tendency to Consume Probiotics in the General Population: An Ecological Study
Rabiee, M., & Mousavi, M. S. (2024) · Modern Care Journal · doi:10.5812/mcj-143404
Doğan, N. M., & Kart, N. N. B. (2024) · Journal of Turkish Sleep Medicine · doi:10.4274/jtsm.galenos.2023.97658
Gareayaghi, N., Teker, Ç., Kılıç, A., Erdoğan, H. K., Teker, F., Özer, A., Nazik, H., Mülayim, M. K., Öztürk, P., Nazik, S., et al. (2022) · Akademisyen Kitabevi eBooks · doi:10.37609/akya.679
Anandamide: From modulation of neuronal excitation to antimicrobial activities—What is in common?
Sionov, R. V., & Steinberg, D. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19081-0.00017-2
Gut-Brain Axis: Probiotics as Psychobiotics
Singh, B., Mal, G., Kalra, R. S., & Marotta, F. (2024) · Springer eBooks · doi:10.1007/978-3-031-65459-6_16
The Endocannabinoid System: The Most Important System You Never Learned in School
Sera, L., & Hempel‐Sanderoff, C. (2025) · Springer eBooks · doi:10.1007/978-3-031-80352-9_1 · Cited by 1
Dedam, J.-P. H., Fogel, M., & Fogel, E. (2025) · Springer eBooks · doi:10.1007/978-3-031-87484-0_3
Microbiome matters: the hidden influence of gut flora on male reproductive health
Navas, F., Hynniewta, B. C., & Marbaniang, K. (2025) · International Journal of Reproduction Contraception Obstetrics and Gynecology · doi:10.18203/2320-1770.ijrcog20252374 · Cited by 1
Los seres que nos habitan: impacto de la microbiota intestinal en el dolor postoperatorio
Lechuga, P. C., Cajal, C. F., Ariza, V. M., & Torrent, A. A. (2025) · Revista Electrónica AnestesiaR · doi:10.30445/rear.v17i8.1345
Bagheri, A. M., Forootanfar, H., Mehrbod, P., Pardakhty, A., Ohadi, M., & Jahanimoghadam, F. (2025) · Medical Hypotheses · doi:10.1016/j.mehy.2025.111781
Ludidi, S. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140903sl
From probiotics to postbiotics: microbial approaches in male reproductive health
Zengin, G., Azkeskin, K., & Kar, F. (2026) · Biological Diversity and Conservation · doi:10.46309/biodicon.2026.1838383
Shen, C., Elmassry, M. M., Kahathuduwa, C. N., Lee, J., Day, M. R., Edwards, D. S., Parmar, H. S., Wager, T. D., Liu, X., Baccus, M., et al. (2026) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2026.103117
Rôle du peptidoglycane et du récepteur NOD2 dans les capacités immunorégulatrices des lactobacilles
Fernandez, E. M. (2011) · theses.fr (ABES) · doi:10.70675/673425edzd9d4z42a2z93c2zbbdfeb2ca7cb
“acidophilus NCFM) favorisent l’expression de récepteurs μ-opioïdes et cannabinoïdes chez les cellules épithéliales intestinales et confèrent un effet analgésique comparable à celui de la morphine (Rousseaux et al., 2007).”
de Chambrun, G. P. (2014) · theses.fr (ABES) · doi:10.70675/30e168cbz82a3z49bbza5e6z2f04d5404ce1
Mazenc, A. (2022) · theses.fr (ABES) · doi:10.70675/993fac83z1efdz4dd2z8639z1373d18cf659
Gomes, P. (2023) · theses.fr (ABES) · doi:10.70675/e62ef6fczef8az47c7za3b7ze3f8b24127a4 · Cited by 1
Lactobacillus acidophilus for infant colic and microbiota modulation: a randomized clinical trial
Vaz, S. R., Tofoli, M. H. C., Avelino, M. A. G., Mota, J. F., Filho, H. B. D. A., & Costa, P. S. (2026) · BMC Pediatrics · doi:10.1186/s12887-026-06883-7 · Cited by 1
“In addition, probiotics may influence the expression of opioid and cannabinoid receptors in intestinal cells [21], in a manner analogous to some actions of morphine [22], thereby affecting neuronal activity and brain function.”
Gut Microbiome, Machine Learning, and Artificial Intelligence Way Forward with Precision Medicine
Patel, R., Dubey, P., Patel, S., Patel, N. A., & Prajapati, B. G. (2026) · Springer eBooks · doi:10.1007/978-981-95-7494-0_12
Gupta, D., Gupta, M. K., Parveen, F., & Agarwal, A. (2026) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2026.200369
Larsen, R., Chakroun, S., Khalilzadehsabet, T., Wallen, O. A., Letourneau-Montminy, M.-P., Flamand, N., Marzo, V. D., de Oliveira, D. E., Rico, J. E., Silvestri, C., et al. (2026) · Animal Nutriomics · doi:10.1017/anr.2026.10041
The Relationship Between (Endo)cannabinoids, the Microbiome and Melanoma
Javid, F. A., Golčić, M., Harej, A., & Belančić, A. (2026) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70304
“In the latter models, changes in the abundance of CB 1 receptor messenger ribonucleic acid (mRNA) were observed in the colon and not in the jejunum [102, 103].”
Endocannabinoids and related lipids in host metabolism–gut microbiome signalling
Silvestri, C., & Marzo, V. D. (2026) · Nature Reviews Endocrinology · doi:10.1038/s41574-026-01289-y
The endocannabinoidome–microbiota axis in obesity: a potential link to colorectal cancer development
Alpino, G. D. C. Á., Brasiel, P. G. D. A., Almeida, M. M., & Luquetti, S. C. P. D. (2026) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-026-01225-8
Castañeda‐Ruelas, G. M., Grijalva-Contreras, L. E., & Quiñonez‐Bastidas, G. N. (2026) · Medical Sciences · doi:10.3390/medsci14050560
“One of the most impactful findings to understand how microbiota regulates the eCBome tone in the gut, driving antinociceptive response, was proposed by Rousseaux et al. [135].”
BindingDB (2015) · UC San Diego · doi:10.7270/q2b859m5
THE ROLE OF CANNABINOIDS AND CANNABINOID RECEPTORS IN ENTERIC NEURONAL SURVIVAL
Li, Y. (2009) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/rszw-w547
Syndrome de l’intestin irritable: traitements conventionnels et alternatifs
Coffin, B. (2011) · Springer eBooks · doi:10.1007/978-2-8178-0237-4_10 · Cited by 2
“Des études chez l’animal ont également montré que certains probiotiques, comme Bacteroides infantis 35624 ou une souche de lactobacillus acidophilus, avaient un effet antalgique et activaient les récepteurs digestifs aux opioïdes (30, 31).”
Background
Metadata
- Authors
- Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., Dubuquoy, C., Merour, E., Geboes, K., Chamaillard, M., Ouwehand, A., Leyer, G., Carcano, D., Colombel, J.-F., Ardid, D., & Desreumaux, P.
- Affiliations
- Inserm (FR)
- Université Clermont Auvergne (FR)
- KU Leuven (BE)
- Corresponding author
- Desreumaux, Pierre
- ORCID
- Venue
- Nature Medicine
- Published
- 2006-12-10
- Volume
- 13
- Issue
- 1
- Pages
- 35-37
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1966470298
- Cited by
- 793
- References
- 16
- Citations by year
- 2026: 15 · 2025: 28 · 2024: 38 · 2023: 46 · 2022: 44 · 2021: 48 · 2020: 42 · 2019: 50 · 2018: 53 · 2017: 40 · 2016: 42 · 2015: 34 · 2014: 47 · 2013: 58 · 2012: 44
- FWCI
- 26.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- Lactobacillus acidophilus, intestinal pain, abdominal pain, irritable bowel syndrome, visceral hypersensitivity, mu-opioid receptor, cannabinoid receptors, intestinal epithelial cells, gut microbiota, analgesia, probiotics
- MeSH terms
- Administration, Oral, Analgesics, Opioid, Animals, Colon, Dose-Response Relationship, Drug, Humans, Indoles, Intestines, Lactobacillus acidophilus, Male, Mice, Inbred BALB C, Morphine, Naloxone, Narcotic Antagonists, Receptors, Opioid, Rectum, Abdominal Pain, Rats, Sprague-Dawley, Receptors, Opioid, mu, HT29 Cells, Probiotics, Receptors, Cannabinoid, Receptor, Cannabinoid, CB2, Mice, Rats, Cannabinoid Receptor Antagonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.